The science of success...

AstraZeneca is a world leading R&D Organisation.  Our Scientists share a common goal - to get life-changing medicines to patients as quickly, safely and efficiently as possible.

Therapy Areas

We focus our resources on six therapy areas where we believe our skills and resources can make the most difference.  These areas include some of the world's most serious illnesses and together, represent a major worldwide burden of disease:

• Cancer
• Cardiovascular
• Gastrointestinal
• Infection
• Neuroscience
• Respiratory and inflammation

Global Research

We employ around 12,000 people at 17 principal R&D centres in 8 countries

In 2008, our R&D spend totalled more than $5 billion

Main R&D facilities

Small molecule research sites:

• UK:  Alderley Park, Macclesfield, Charnwood and London (Arrow Therapeutics)
• Sweden:  Lund, Molndal and Sodertalje
• US:  Boston MA and Wilminton DE
• Canada:  Montreal QC
• France:  Reims
• India:  Bangalore
• China:  Shanghai
• Japan:  Osaka (Clinical development)

Medimune biologics and vaccines research sites:

• US:  Gaithersburg MD and Mountain View CA
• UK:  Cambridge

Local Impact

AstraZeneca Australia has been working to improve patient health for over half a century.

• $10 million invested in R&D in 2007
• Over 50 clinical trials at 200 sites across Australia
• Trials investigating potential new tratments and new approaches in all therapy areas.

For more information on AstraZeneca's research efforts, please visit our international site:  www.AstraZeneca.com